Cochlear, Telix, and other ASX-listed businesses have confirmed their tariff-free status, as others face 10% duties on exports to the US.

Let's see what the broker is saying about these healthcare stocks. The post Trump 2.0: Macquarie's take on the winners and ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

The concept of constructing a self-supporting structure made of rods—without the use of nails, ropes, or glue—dates back to ...

Australia’s hearing implant giant Cochlear (ASX:COH) has clarified an April 3 release, stating its hearing implants do fall ...

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor ...

Scientists used a brain implant and generative AI to give a woman her voice back and help her talk in near real time.

Fundsmith’s latest factsheet covering March 2025 lists the following companies as its five biggest positions: Meta Platforms ( NAS: META ), Microsoft, Stryker ( NYS: SYK ), Philip Morris ( NYSE: PM) ...

China vows to hit back at Trump’s tariffs which total 54pc; pharmaceuticals, semiconductors and gold have been excluded but ...

Cochlear Ltd (ASX: COH) shares have been in the spotlight today. Let's see what impact Trump's tariffs could have on the ...

Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough ...

Envoy Medical (NASDAQ:COCH – Get Free Report) will likely be releasing its earnings data before the market opens on Monday, April 7th. Analysts expect Envoy Medical to post earnings of ($0.33) per ...